Jai Surgicals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-12-2024
- Paid Up Capital ₹ 1.13 Cr
as on 24-12-2024
- Company Age 44 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.71 Cr
as on 24-12-2024
- Revenue 11.30%
(FY 2021)
- Profit 91.47%
(FY 2021)
- Ebitda 92.61%
(FY 2021)
- Net Worth 25.44%
(FY 2021)
- Total Assets 20.68%
(FY 2021)
About Jai Surgicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.13 Cr.
The company currently has active open charges totaling ₹8.71 Cr.
Pankaj Kehr, Philip Thomas, Gaurav Rawal, and One other member serve as directors at the Company.
- CIN/LLPIN
U45201HR1980PLC036012
- Company No.
036012
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 May 1980
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jai Surgicals Limited offer?
Jai Surgicals Limited offers a wide range of products and services, including Scalpels, Needles & Scissors, Surgical Blades.
Who are the key members and board of directors at Jai Surgicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Philip Thomas  | Director | 01-Apr-2006 | Current |
| Pankaj Kehr | Whole-Time Director | 01-May-1996 | Current |
| Gaurav Rawal | Director | 01-Apr-2006 | Current |
| Sanjiv Kehr | Whole-Time Director | 01-Apr-1996 | Current |
Financial Performance of Jai Surgicals.
Jai Surgicals Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 11.3% increase. The company also saw a substantial improvement in profitability, with a 91.47% increase in profit. The company's net worth Soared by an impressive increase of 25.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jai Surgicals?
In 2022, Jai Surgicals had a promoter holding of 83.20% and a public holding of 16.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 30 Aug 2008 | ₹1.01 Cr | Open |
Canara Bank Creation Date: 08 May 1987 | ₹7.70 Cr | Open |
How Many Employees Work at Jai Surgicals?
Jai Surgicals has a workforce of 133 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jai Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jai Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
